Litcius/Paper detail

Nitrogen-containing heterocyclic drug products approved by the FDA in 2023: Synthesis and biological activity

Weijiang Luo, Yiqi Liu, Hui Qin, Zeyan Zhao, Suqi Wang, Wei‐Min He, Shengsong Tang, Junmei Peng

2024European Journal of Medicinal Chemistry82 citationsDOIOpen Access PDF

Topics & Concepts

ChemistryPyridazineIsoxazolePharmacologyOxazoleDrugStereochemistryMedicineSynthesis and Biological EvaluationAdenosine and Purinergic SignalingFluorine in Organic Chemistry
Nitrogen-containing heterocyclic drug products approved by the FDA in 2023: Synthesis and biological activity | Litcius